Vitamin d and chronic disease prevention

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Welsh, Paul ^a   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTIHYPERTENSIVE AGENT; COLECALCIFEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OMEGA 3 FATTY ACID; VITAMIN D;

AUTOIMMUNITY; BIRTH WEIGHT; BONE DISEASE; BONE MINERAL; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERCALCEMIA; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SUN EXPOSURE; VITAMIN SUPPLEMENTATION;

HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84898014327     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2280     Document Type: Editorial

References (22)

1. National Research Council. Dietary reference intakes for calcium and vitamin D. National Academies Press, 2011.
2. Hopkinson JA, Hopkinson NS. The hobbitan unexpected deficiency. Med J Aust 2013;199:805-6.
3. Boseley S. Sunshine and vitamin D: why cloudy skies are bad for our health. The Guardian 2012 May 5. www.theguardian.com/society/2012/may/05/ vitamin-d-deficiency-sunlighthealth.
4. Blair M. Action needed on vitamin D levels. BBC News 2012 Dec 14. www.bbc.co.uk/ news/health-20710026.
5. Theodoratou E, Tzoulaki I, Lina Z, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035.
6. Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2013;159:824-34.
7. Bjelakovic G, Nikolova D, Gluud L, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;(3):CD007176.
8. Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, et al, for the Korean Meta-Analysis Study Group. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013;346:f10.
9. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomized trial evidence? Lancet 2004;363:1724-7. (Pubitemid 38670332)
10. Welsh P, Peters MJ, Sattar N. Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementation. Arthritis Rheum 2011;63:1763-9.
11. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013;10:e1001383.
12. Reid D, Toole BJ, Knox S, Talwar D, Harten J, OReilly DS, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011;93:1006-11.
13. Chowdhury R, Kunutsor, S, Vitezova A, Oliver-Williams C, Kiefte-de Jong J, Khan H, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of prospective observational and randomised intervention studies. BMJ 2014;348:g1903.
14. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011;(7):CD007470.
15. Van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J 2012;33:2088-97.
16. Cholesterol Treatment Trialists (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.
17. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014; published online 24 Jan (available at www.thelancet.com/journals/landia/article/PIIS2213-8587(13)70212- 2/abstract).
18. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014;383:146-55.
19. Lightwood R. Hypercalcaemia in infants and vitamin D. BMJ 1956;2:149.
20. Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410-21.
21. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012;33:159-71.
22. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379:95-6.